NSE Ancillary Study of The Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.
Also called NCT02722473
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose diagnostic
- Phase
- Phase 3
- Enrolled
- 106 participants
- Registry
-
NCT02722473
-
- Other papers using this trial's data
- NSE as a predictor of death or poor neurological outcome after non-shockable cardiac arrest due to any cause: Ancillary study of HYPERION trial data
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT02722473. Randomized; single masking; primary purpose diagnostic. Start 2016-03 (registry gives no type); primary completion 2018-01-14 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- NSE Ancillary Study of The Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.
- Acronym
- NSE-HYPERION
- Condition
- Cardiac Arrest
- Condition
- Hypothermia
- Condition
- Critical Care
- Intervention (Biological)
- NSE dosage "hypothermia arm"
- Intervention (Biological)
- NSE dosage "normothermia arm"
- Lead sponsor
- Centre Hospitalier Departemental Vendee
Record details
- Record id
cardio:ct-nct02722473- Content hash
d2ebeef628639eb18aceb704e518234c6505683bde2ad3c7c172aadd6a408c76